PA-83-FhCMB

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NamePA-83-FhCMB

Drug Alias NamePlant derived recombinant protective antigen anthrax vaccinerPA anthrax vaccine (iBio/Fraunhofer USA Center for Molecular Biotechnology)PA-83-FhCMBPA83-FhCMB

ClassificationVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsAnthrax

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesIbio Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesFraunhofer, Center For Molecular Biotechnology

Active IndicationsN/A

Inactive IndicationsAnthrax

Other Information

ATC CodeN/A